M. Sc. and Ph. D. in Human Genetics. Genetic research scientist with 17+ years’ experience facilitating affordable and innovative breakthroughs in personalized medicine by managing high-level research projects and investigations that study biological processes using in silico and in vitro approaches.

      Dedicated to analyzing and translating research findings into innovative ideas that shape next-generation therapies and affect the delivery of products to market. I have published 30 peer-reviewed articles collaborating with research groups in USA, UK, Germany, and Mexico.

    Reviewer of +20 journals including:

· Frontiers in Immunology, 2022, 2023

· Frontiers in Microbiology, 2022, 2023

· European Journal of Pharmacology, 2022

· Genes and Immunity, 2020

· Genetic Testing and Molecular Biomarkers, 2020

· Genetics and Molecular Biology, 2018

· Bioorganic & Medicinal Chemistry, 2018

· Peer J, 2017

· Journal of Nursery and Midwifery, 2017

· Biopolymers: Peptide Science, 2016

· International Journal of Genomics, 2016

· AIMS Public Health, 2015

· British Journal of Pharmaceutical Research, 2014

· Recent Patents on Anti-Infective Drug Discovery, 2014

· Current Respiratory Medicine Reviews, 2014

· Elsevier Reviews (chapter), 2014

· British Microbial Research Journal, 2013

· Recent patents on Biotechnology, 2013

· British Journal of Medicine and Medical Research, 2013

· Mycobacterial diseases: tuberculosis and leprosy, 2013

· Biomed Research International, 2013

· International Journal of Dermatology, 2010, 2012, 2013, 2014, 2021

· J Dermatology, 2011

· Innate Immunity, 2010

· British Journal of Dermatology, 2007

Proficient in scientific research writing, including editing, rewriting, formatting, and proofreading original manuscripts for publication, grant proposals, patent writing, and submission as well as study protocols with scientific and technical precision.

Selected Achievements:

· Engineered proprietary software: SNPClinic v.1.0 leveraged to discover rSNPs in human promoters (specificity= 85%) by integrating a semiautomatic process that analyzes relevant information about human gene regulation from 1000 genomes project, ENCODE, and relevant databases (JASPAR/TRANSFAC, Ensembl).

· Recipient of multiple awards, fellowships, and scholarships: Wellcome Trust (UK, seven scholarships), European Molecular Biology Laboratory (Germany, five scholarships), Bill & Melinda Gates Foundation (USA, 10 Global Health Awards), RELAB-UNESCO (Argentina-France, scholarship), Guadalajara University (Mexico, two scholarships + Academic Excellence Award), UNAM-European Community (1 scholarship), IMSS (three-year fellowship + Award to merit in research), CONAHCYT (6 grants, + 15 years of SNI Fellow Excellence Research monthly stipend), EULAC PerMed (Spain-Italy, scholarship), COECYTJAL (2 grants), and German Healthcare Partnership (scholarship).

· First inventor/primary contributor of three granted patents: antimicrobial peptide elicitor (potential first-in-class antiviral and antibacterial drug), an antimicrobial peptide inhibitor (potential first-in-class drug against autoimmune diseases), and a UVA/UVC lamp (for the treatment of skin cancer/melanoma and local infections).

· 16+ years of experience designing, setting up, and certifying (ISO) R&D molecular diagnostics and genetic markers laboratories in industrial and academic settings.

· 8+ years of experience designing, setting up, and certifying (different ISO Norms) the Personalized Medicine National Laboratory LAMPER (Mexico) including core computational facilities for R&D with capabilities to serve both industrial and academic needs.